Skip to main content
Caplight Logo









Geltor

Geltor

Private
San Leandro, CaliforniaHealthcare & Life Scienceshttps://geltor.com/

Last Round

VC Round

Aug 6, 2025

Total Funding Raised

$114.25M

Company Overview

Geltor is a biotechnology company that produces animal-free, biodesigned proteins for the beauty, nutrition, and food and beverage industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Sustainable Materials, Fashion & Beauty, Clean Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

animal-free proteinvegan collagenlab-grown proteinprecision fermentationbiodesigned ingredientssynthetic biologybiotech beautycellular agriculturebio-identical proteincosmetic ingredientssustainable beautyprotein designclean beautyingredients-as-a-servicePaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Geltor Comparables

Compare Geltor with similar companies based on industry and business-model similarity.

Geltor comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cambrium
84%
Jiangsu Jland Biotech Co., Ltd.
83%
Debut
81%

Geltor Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundAug 6, 2025
Series BJul 27, 2020
Series AOct 25, 2018
SeedOct 1, 2015

Key People

Founding team and executive leadership

Nick Ouzounov

Co-Founder And CTO

Founding Team

Alexander Lorestani

Co-Founder and CEO

Founding Team

Geltor Investors

Notable investors and investment history

Geltor investors
InvestorRounds
KBW VenturesSeries A
iSelect FundSeries B, VC Round
Gelita AGSeries A, Series B
ADM VenturesSeries A, Series B
FTW VenturesSeries B
Cultivian Sandbox VenturesSeries B, Series A
Beyond Impact AdvisorsSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 22, 2026

    Launched Signaling Collagen Shot for skin health.

  • Jul 27, 2020

    $91M round led by CPT Capital.

Geltor Filings

Explore SEC and related filing metadata, where available.

Geltor filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Geltor's valuation, stock price, and market status.

Is Geltor a public or private company?

Geltor is a private company.

What is the current stock price of Geltor?

Geltor is a private company with no public stock price. No recent secondary market data is available.

How much is Geltor worth (valuation)?

Valuation information for Geltor is not publicly available.

Can I buy Geltor stock?

Geltor shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Geltor's last funding round?

Geltor's most recent funding round was VC Round on August 6, 2025.

Who are the main investors in Geltor?

Key investors in Geltor include iSelect Fund, Cultivian Sandbox Ventures, CPT Capital, Starlight Ventures.

Will Geltor IPO soon?

No public IPO plans have been announced for Geltor.

How can I track Geltor secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Geltor's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Leandro, California
Employee Range12
Year Founded2015
Last FundingAug 6, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?